Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bisoprolol
Drug ID BADD_D00277
Description Bisoprolol is a cardioselective β1-adrenergic blocking agent used to treat high blood pressure.[A180472,L7219] It is considered a potent drug with a long-half life that can be used once daily to reduce the need for multiple doses of antihypertensive drugs.[A180472] Bisoprolol is generally well tolerated, likely due to its β1-adrenergic receptor selectivity and is a useful alternative to non-selective β-blocker drugs in the treatment of hypertension such as [Carvedilol] and [Labetalol]. It may be used alone or in combination with other drugs to manage hypertension[L7219] and can be useful in patients with chronic obstructive pulmonary disease (COPD) due to its receptor selectivity.[A180562]
Indications and Usage For management of heart failure, angina pectoris, and mild to moderate hypertension and for secondary prevention of myocardial infarction (MI).
Marketing Status Prescription; Discontinued
ATC Code C07AB07
DrugBank ID DB00612
KEGG ID D02342
MeSH ID D017298
PubChem ID 2405
TTD Drug ID D0K3ZR
NDC Product Code Not Available
Synonyms Bisoprolol | Bisoprolol Fumarate (1:1) Salt, (+-)-Isomer | Bisoprolol Fumarate (2:1) Salt, (+-)-Isomer | Bisoprolol Hydrochloride | Hydrochloride, Bisoprolol | Bisoprolol Methanesulfonate Salt | Bisoprolol, (+-)-Isomer | Bisoprolol, Fumarate (1:1) Salt | Bisoprolol, Fumarate (2:1) Salt | CL-297939 | CL 297939 | CL297939 | Concor | EMD-33512 | EMD 33512 | EMD33512 | Bisoprolol Fumarate | Fumarate, Bisoprolol | Bisoprolol, (-)-Isomer
Chemical Information
Molecular Formula C18H31NO4
CAS Registry Number 66722-44-9
SMILES CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Abnormal dreams17.15.02.001; 19.02.03.001--Not Available
Actinic keratosis23.01.06.0010.004025%Not Available
Acute hepatic failure09.01.03.0010.001342%Not Available
Acute myeloid leukaemia01.10.05.001; 16.01.05.0010.000525%Not Available
Acute myocardial infarction02.02.02.001; 24.04.04.001--Not Available
Acute psychosis19.03.01.0010.002013%Not Available
Acute pulmonary oedema02.05.02.004; 22.01.03.0050.003354%Not Available
Acute respiratory failure14.01.04.004; 22.02.06.0010.000525%Not Available
Ageusia07.14.03.003; 17.02.07.001--Not Available
Agitation17.02.05.012; 19.06.02.0010.006038%
Agranulocytosis01.02.03.0010.005367%Not Available
Akathisia17.01.02.002; 19.06.02.0060.002683%
Alopecia23.02.02.001--
Altered state of consciousness17.02.04.001; 19.07.01.003--Not Available
Amnesia17.03.02.001; 19.20.01.0010.005367%
Anaemia01.03.02.0010.016771%
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock10.01.07.002; 24.06.02.0040.006038%Not Available
Aneurysm24.02.01.0010.000525%Not Available
Angina pectoris02.02.02.002; 24.04.04.0020.005367%
Angina unstable02.02.02.004; 24.04.04.0040.001342%Not Available
Angioedema10.01.05.009; 23.04.01.0010.010063%Not Available
Ankle fracture12.04.01.005; 15.08.03.0050.002013%
Anosmia17.04.04.001; 22.04.03.006--
Anuria20.01.03.0020.002013%Not Available
Anxiety19.06.02.002--
The 1th Page    1 2 3 4 5    Next   Last    Total 20 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene